Interleukins as biomarkers of non-alcoholic steatohepatitis severity in hypertensive patients
| dc.contributor.author | Rozhdestvenska, Anastasiia | |
| dc.contributor.author | Zhelezniakova, Natalia | |
| dc.date.accessioned | 2023-05-20T15:33:48Z | |
| dc.date.available | 2023-05-20T15:33:48Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Nonalcoholic steatohepatitis (NASH) is defined as a more severe stage of nonalcoholic fatty liver disease. Pathology is often associated with an imbalance of pro-inflammatory and anti-inflammatory cytokines (in particular, interleukin-1β (IL-1β) and interleukin-10 (IL-10), respectively). Prevention of irreversible complications of the disease requires early diagnosis of liver fibrosis. This issue is especially relevant for patients with concomitant hypertension (HT), which complicates the NAFLD. | en_US |
| dc.identifier.citation | Rozhdestvenska A. Interleukins as biomarkers of non-alcoholic steatohepatitis severity in hypertensive patients / A. Rozhdestvenska, N. Zhelezniakova // Медицина третього тисячоліття : Фестиваль молодіжної науки, Харків, 13–15 лютого 2023 року : збірник тез конференції / Харківський національний медичний університет. – Харків : ХНМУ, 2023. – С. 66–67. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/32075 | |
| dc.language.iso | en | en_US |
| dc.subject | NASH | en_US |
| dc.subject | hypertension | en_US |
| dc.subject | biomarkers | en_US |
| dc.subject | interleukins | en_US |
| dc.title | Interleukins as biomarkers of non-alcoholic steatohepatitis severity in hypertensive patients | en_US |
| dc.type | Thesis | en_US |